This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
3 Insurance Stocks With 25% YTD Gains Still Have Room to Run
by Tanuka De
Banking on strong fundamentals and benefiting from a favorable macro backdrop, WRB, UNM, and KNSL have not only outperformed the industry but have also crushed the market and the Finance sector. These are well-poised to sustain the bull run next year.
Should You Retain Axis Capital (AXS) Stock in Your Portfolio?
by Zacks Equity Research
Increases in lines of business, new business growth, continued strong retentions, accelerated digitalization and prudent capital deployment continue to drive AXIS Capital (AXS).
Here's Why You Should Retain RLI Stock in Your Portfolio
by Zacks Equity Research
RLI stands to gain from compelling product portfolio, sustained rate increase, expanded distribution and operational strength and sufficient liquidity.
W.R. Berkley (WRB) Stock Moves -1.29%: What You Should Know
by Zacks Equity Research
In the latest trading session, W.R. Berkley (WRB) closed at $72.05, marking a -1.29% move from the previous day.
Progressive (PGR) November Earnings and Revenues Rise Y/Y
by Zacks Equity Research
Progressive's (PGR) November earnings reflect higher revenues, partially offset by higher expenses.
Unum Group (UNM) Up 63.6% in a Year: More Room to Run?
by Zacks Equity Research
Unum Group (UNM) stock rallies on the back of higher sales, higher persistency, improving premium income and prudent capital deployment.
Travelers (TRV) Up 15.2% in a Year: More Room for Growth?
by Zacks Equity Research
Travelers (TRV) stock rallies on the back of higher average levels of invested assets, positive renewal premium change and effective capital deployment.
Are Investors Undervaluing Mercury General (MCY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights Enphase Energy, Halliburton, Cardinal Health and W.R. Berkley
by Zacks Equity Research
Enphase Energy, Halliburton, Cardinal Health and W.R. Berkley are included in this Analyst Blog.
W.R. Berkley (WRB) Stock Moves -0.12%: What You Should Know
by Zacks Equity Research
In the latest trading session, W.R. Berkley (WRB) closed at $72.99, marking a -0.12% move from the previous day.
Kinsale (KNSL) Up 28.9% in a Year: Can It Maintain the Upside?
by Zacks Equity Research
Kinsale (KNSL) stock rallies on the back of technology-driven low-cost operation, strong premium growth, higher net-earned premiums and effective capital deployment.
Progressive (PGR) Stock Up 25% YTD: Will the Bull Run Continue?
by Zacks Equity Research
An attractive product portfolio, leadership position, strength in Vehicle and Property businesses, healthy policies in force, retention and solid capital position continue to drive Progressive (PGR).
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
4 S&P 500 Stocks Up More Than 30% YTD With More Room to Run
by Madhurima Das
Despite the S&P 500 incurring a 15.7% YTD loss owing to inflation and high interest rates, stocks like ENPH, HAL, CAH and WRB have soared. They are poised to maintain the momentum in 2023.
Here is Why Growth Investors Should Buy W.R. Berkley (WRB) Now
by Zacks Equity Research
W.R. Berkley (WRB) could produce exceptional returns because of its solid growth attributes.
If You Invested $1000 in W.R. Berkley a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Here's Why Investors May Consider Betting on W.R. Berkley (WRB)
by Zacks Equity Research
W.R. Berkley (WRB) is poised to benefit from higher premiums, growing underwriting profits, reductions in loss ratio and effective capital deployment.
WRB or TKOMY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
WRB vs. TKOMY: Which Stock Is the Better Value Option?
4 Stocks You'll Regret Not Buying at Their Current Price Levels
by Vasundhara Sawalka
Here we present four stocks, CMC, DDS, WRB and BOKF, which look attractive at their current price level and are poised for growth in the near term.
W.R. Berkley (WRB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
W.R. Berkley (WRB) closed the most recent trading day at $74.44, moving -0.28% from the previous trading session.
5 Stocks Your Portfolio Must Have Amid Persisting Volatility
by Nalak Das
We have narrowed our search to five large-cap, low-beta and dividend paying stocks that have popped over 25% year to date with more upside left. These are: ADM, GL, LPLA, WRB and SQM.
W.R. Berkley (WRB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, W.R. Berkley (WRB) closed at $75.67, marking a +0.48% move from the previous day.
3 Top Market-Beating Stocks to Buy in December for More Growth
by Benjamin Rains
Here are three highly-ranked Zacks stocks that have crushed the market in 2022 and are poised to post strong growth in 2023 as well.
Lincoln National (LNC) Strengthens Hospital Indemnity Solution
by Zacks Equity Research
Lincoln National (LNC) integrates three benefits within the Hospital Indemnity solution to address the unexpected hospitalization expense problem of Americans.
W.R. Berkley Corporation (WRB) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
W.R. Berkley (WRB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.